🇪🇺 Tasigna in European Union

Tasigna (NILOTINIB) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/000798
  • Local brand name: Tasigna
  • Status: approved

Tasigna in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in European Union

Frequently asked questions

Is Tasigna approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Tasigna in European Union?

Cipla is the originator. The local marketing authorisation holder may differ — check the official source linked above.